Graves' ophthalmopathy (GO) represents the most common extrathyroidal
manifestations of Graves' disease. Recently, several important molecul
ar and biochemical details concerning both cellular and humoral mechan
isms in the pathogenesis of GO have been elucidated. Clinically, the o
rbital manifestations of Graves' disease derive mainly from the mechan
ical complications caused by expansion of the connective, adipose and
muscle tissue compartments within the confines of the bony orbits. Dia
gnosis of GO by a detailed history, clinical examination of the patien
t, and detection of hyperthyroidism or thyroid dysregulation, is usual
ly straightforward. Imaging of the orbital contents by ultrasonography
, computed tomography or magnetic resonance imaging is rarely required
, but should be performed to rule out important differential diagnoses
or in patients with complicated GO. Whenever possible, management of
patients with GO should be interdisciplinary (primary care, endocrinol
ogy, ophthalmology, radiation therapy), tailored to the individual nee
ds to the patient, and include a careful and long-term follow-up.